These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28545714)

  • 21. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.
    Jamadar A; Suma SM; Mathew S; Fields TA; Wallace DP; Calvet JP; Rao R
    Cell Death Dis; 2021 Oct; 12(10):947. PubMed ID: 34650051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.
    Patera F; Cudzich-Madry A; Huang Z; Fragiadaki M
    Sci Rep; 2019 Mar; 9(1):4491. PubMed ID: 30872773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 24. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
    Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nedd9 restrains renal cystogenesis in Pkd1-/- mice.
    Nikonova AS; Plotnikova OV; Serzhanova V; Efimov A; Bogush I; Cai KQ; Hensley HH; Egleston BL; Klein-Szanto A; Seeger-Nukpezah T; Golemis EA
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12859-64. PubMed ID: 25139996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells.
    Xu JX; Lu TS; Li S; Wu Y; Ding L; Denker BM; Bonventre JV; Kong T
    Physiol Genomics; 2015 Feb; 47(2):24-32. PubMed ID: 25492927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steviol stabilizes polycystin 1 expression and promotes lysosomal degradation of CFTR and β-catenin proteins in renal epithelial cells.
    Yuajit C; Muanprasat C; Homvisasevongsa S; Chatsudthipong V
    Biomed Pharmacother; 2017 Oct; 94():820-826. PubMed ID: 28802235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model.
    He J; Zhang S; Qiu Z; Li X; Huang H; Jin W; Xu Y; Shao G; Wang L; Meng J; Wang S; Geng X; Jia Y; Li M; Yang B; Jenny Lu HA; Zhou H
    J Am Soc Nephrol; 2021 Sep; 32(9):2159-2174. PubMed ID: 34465607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8
    Kleczko EK; Marsh KH; Tyler LC; Furgeson SB; Bullock BL; Altmann CJ; Miyazaki M; Gitomer BY; Harris PC; Weiser-Evans MCM; Chonchol MB; Clambey ET; Nemenoff RA; Hopp K
    Kidney Int; 2018 Dec; 94(6):1127-1140. PubMed ID: 30249452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation.
    Fan LX; Li X; Magenheimer B; Calvet JP; Li X
    Kidney Int; 2012 Jan; 81(1):76-85. PubMed ID: 21900881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.
    Zhu P; Sieben CJ; Xu X; Harris PC; Lin X
    Hum Mol Genet; 2017 Jan; 26(1):158-172. PubMed ID: 28007903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells.
    Asawa RR; Danchik C; Zakharov A; Chen Y; Voss T; Jadhav A; Wallace DP; Trott JF; Weiss RH; Simeonov A; Martinez NJ
    Sci Rep; 2020 Mar; 10(1):4203. PubMed ID: 32144367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
    Seo S; Kim H; Hwang JT; Kim JE; Kim J; Jeon S; Song YJ; Choi KH; Sim G; Cho M; Yoon JW; Kim H
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.
    Mohammad RM; Li Y; Muqbil I; Aboukameel A; Senapedis W; Baloglu E; Landesman Y; Philip PA; Azmi AS
    Small GTPases; 2019 Sep; 10(5):367-377. PubMed ID: 28641032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell Proliferation and Apoptosis in ADPKD.
    Lee EJ
    Adv Exp Med Biol; 2016; 933():25-34. PubMed ID: 27730432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
    Dasgupta A; Sierra L; Tsang SV; Kurenbekova L; Patel T; Rajapakse K; Shuck RL; Rainusso N; Landesman Y; Unger T; Coarfa C; Yustein JT
    Cancer Res; 2021 Jan; 81(1):199-212. PubMed ID: 33168646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.